Stockscreener 앱 받기
0.9801
3.91%
-0.0399
Waldencast Plc 주식(WALD)의 최신 뉴스
Risk Analysis: Can Waldencast plc Equity Warrant outperform in the next rally2026 Bull vs Bear & Detailed Earnings Play Strategies - baoquankhu1.vn
Volatility Watch: Will Waldencast plc benefit from rising consumer demandTrade Risk Report & Fast Moving Stock Watchlists - baoquankhu1.vn
Volatility Watch: What are the future prospects of Waldencast plcRate Hike & Momentum Based Trading Ideas - baoquankhu1.vn
Aug Catalysts: Is Waldencast plc Equity Warrant stock a value trapPrice Action & Target Return Focused Stock Picks - baoquankhu1.vn
Waldencast PLC (NASDAQ:WALD) Short Interest Up 61.6% in March - MarketBeat
This $175 serum says it can make skin look up to 6 years younger - Stock Titan
Aug Technicals: Can Waldencast plc Equity Warrant outperform in the next rally2026 Highlights & Long-Term Capital Growth Strategies - baoquankhu1.vn
Waldencast (WALD) Oppenheimer's 24th Annual Consumer Growth and E-Commerce Conference summary - quartr.com
Obagi Medical and ProMD Announce Collaboration in the ALOHA - GlobeNewswire
17 ProMD clinics across states will evaluate Obagi's MagIQ - Stock Titan
Waldencast plc (WALD) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Waldencast (WALD) CEO Michel Brousset reports options, RSUs and indirect stakes - Stock Titan
Waldencast (WALD) director details large indirect share, warrant and option holdings - Stock Titan
Waldencast plc (WALD) director reports direct and indirect share stakes - Stock Titan
[Form 3] Waldencast plc Initial Statement of Beneficial Ownership - Stock Titan
Waldencast (WALD) director lists 37,454 Class A Ordinary Shares - Stock Titan
Waldencast (WALD) director details initial share and RSU holdings - Stock Titan
Waldencast (WALD) director Felipe Dutra files initial Form 3 ownership report - Stock Titan
[Form 3] Waldencast plc Initial Stateme... - Stock Titan
Waldencast (WALD) executive Hind Sebti details options, RSUs and shares - Stock Titan
Canaccord cuts Waldencast stock price target on elevated costs By Investing.com - Investing.com South Africa
Canaccord cuts Waldencast stock price target on elevated costs - Investing.com
WALD: Telsey Advisory Group Lowers Price Target to $2.00, Mainta - GuruFocus
Analysts Offer Insights on Consumer Goods Companies: American Public Education (APEI) and Waldencast (WALD) - The Globe and Mail
Waldencast (WALD) Trailing US$229.7 Million Loss Reinforces Bearish Profitability Narratives - Sahm
Waldencast Acquisition earnings missed by $0.18, revenue fell short of estimates - Investing.com UK
Waldencast plc Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Waldencast Q4 2025 Earnings: Revenue Flat at $72M as Brand Transformation Takes Shape - technotrenz.com
Waldencast Q4 Financial Results Analysis - Intellectia AI
Waldencast Posts Flat 2025 Results as Obagi Surges, Launches Strategic Review and Deleveraging Drive - TipRanks
Waldencast Reports Q4 2025 and FY 2025 Financial Results - The Manila Times
Waldencast Reports Flat FY 2025 Revenue of $272.1 Million, Highlights Strategic Advancements in Beauty and Wellness Brands - Quiver Quantitative
CORRECTED-BRIEF-Waldencast plc. Q4 Adjusted EBITDA USD 6.6 Million - TradingView
WALDWaldencast plc Latest Stock News & Market Updates - Stock Titan
Waldencast (NASDAQ: WALD) posts larger 2025 loss as EBITDA drops - Stock Titan
Big impairments and control risks at Waldencast (Nasdaq: WALD) in 2025 filing - Stock Titan
Quarterly Risk: Will Waldencast plc stock benefit from M A2026 Dividend Review & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Waldencast (WALD) Projected to Post Quarterly Earnings on Thursday - Defense World
Waldencast plc to Release Fourth Quarter and Fiscal Year 2025 Earnings Report on March 11, 2026 - geneonline.com
Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date - Bitget
Price Action: Can Waldencast plc disrupt its industryJuly 2025 Review & Free High Return Stock Watch Alerts - baoquankhu1.vn
Quarterly Trades: Can Waldencast plc Equity Warrant navigate macro headwindsJuly 2025 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
WALD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
WALD Should I Buy - Intellectia AI
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ - The Globe and Mail
Schweiger clinics to trial new Obagi injectable in real-world ALOHA program - Stock Titan
New Highs: Is Waldencast plc Equity Warrant stock a value trapEarnings Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Guidance Update: Can Waldencast plc Equity Warrant outperform in the next rallyFed Meeting & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Obagi Medical and It's a Secret Med Spa announce collaboration in the Aloha program - marketscreener.com
Latest WALD NewsWaldencast Announces Entry into $225m Term ... - Stock Titan
Obagi Medical and It’s a Secret Med Spa Announce - GlobeNewswire
Luxury med spa chain to evaluate Obagi’s new ALOHA hyaluronic injectable - Stock Titan
Does Waldencast plc Equity Warrant have a sustainable dividendIPO Watch & Weekly Return Optimization Alerts - mfd.ru
Will Waldencast plc Equity Warrant face regulatory challengesMarket Sentiment Summary & Weekly Breakout Stock Alerts - mfd.ru
How The Waldencast (WALD) Narrative Is Shifting As Outlook Resets Meet Brand Optimism - Yahoo Finance
Earnings Report: Can Waldencast plc Equity Warrant navigate macro headwindsLong Setup & Real-Time Buy Zone Alerts - baoquankhu1.vn
Waldencast plc (WALD) Acquired Novaestiq Corp. and the US Rights to the Saypha Line of Hyaluronic Acid Injectable Gels - MSN
Waldencast outlines mid-teens revenue growth for 2025 backed by brand expansion - MSN
Downgrade Watch: Can Waldencast plc Equity Warrant outperform in the next rallyTrade Signal Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Obagi Medical and Aesthetic Record Announce Collaboration - GlobeNewswire
1.04%
1.58%
자본화:
|
볼륨(24시간):